Brief: Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease
02/04/2025 13:17
April 2 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP LAUNCHES FIRST-OF-ITS-KIND IMMUNOASSAY TO ACCELERATE PATH TO DIAGNOSIS OF ALZHEIMER'S DISEASE Source text: ID:nPnbbJGzTa Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health
U.S. STOCKS ON THE MOVE-Royal Caribbean, Labcorp, Textron